ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 455

Validity, Reliability and Sensitivity to Change of Four Different Patient-Reported Outcomes (PROs) to Measure the Domains Pain, Fatigue, Experienced Disease Activity and General Well-Being in Patients with Rheumatoid Arthritis

Lisanne Renskers1, Piet L.C.M. van Riel2,3 and Ron J.J.C. van Uden1, 1IQ healthcare, Radboud university medical center, Radboud Institute for Health Sciences, IQ healthcare, Nijmegen, Netherlands, 2Radboud university medical center, Radboud Institute for Health Sciences, IQ healthcare, Nijmegen, Netherlands, 3Bernhoven, Department of Rheumatology, Uden, Netherlands

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: patient preferences, patient-reported outcome measures and rheumatoid arthritis (RA), Validity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Quality Measures and Quality of Care - ARHP Poster

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: With Patient-Reported Outcomes (PROs), the patient’s perspective can be assessed. Several forms can be used; Verbal Rating Scale (VRS), Numerical Rating Scale (NRS), Visual Analog Scale (VAS) and Likert-scale. Since contradictory findings exist with regard to advantages and disadvantages of these scales, the aim of this study was to assess the clinimetric properties (using OMERACT 2.0 filter) of these scales for the measurement of pain, fatigue, experienced disease activity (DA) and general well-being and to ask patients which scale they prefer most.

Methods: Patients (all fulfilling ACR criteria for RA) visiting the rheumatology outpatient clinic Bernhoven (Uden, the Netherlands) were included. They filled in a questionnaire directly after their visit, consisting of 21 items in 4 domains using VRS, NRS, VAS and 5-point Likert scale. They were asked to fill in the same questionnaire 5 days after their visit and return it in a self-addressed envelope. DAS28(3) scores were calculated (absence of VAS global rating). Regarding truth, Pearson correlations with DAS28(3) were used for validity analysis. Regarding discrimination, Pearson correlations were used for reliability analysis and paired sample t-tests for sensitivity to change (patients in this group were treated with 120 mg methylprednisolone). Regarding feasibility, patients indicated which scale they preferred most.

Results: Two hundred fifty-seven patients (63% female) filled in the first questionnaire, of which 184 patients filled in questionnaire two. Mean DAS28(3) score was 3.16 (±1.15). Concerning truth, 211 stable patients were included for validity analysis. The highest correlation coefficient was found for NRS in the domain pain (r = 0.41, p < 0.001). On fatigue and DA VAS scored best, while Likert scored best on general well-being. With regard to discrimination, 153 patients were eligible for the reliability analysis, 31 patients for the sensitivity to change analysis. For fatigue NRS was most reliable (r = 0.853, p < 0.001). VAS was most reliable to measure pain and DA, while Likert scored best on general well-being. Regarding sensitivity to change, VAS pain was most sensitive (t = 2.843, p < 0.005), followed by Likert pain and NRS pain (t = 2.340 and t = 2.151 respectively, both p < 0.05). Patient indicated NRS as overall scale preference (first questionnaire 47.9%, second questionnaire 48.4%). Besides that, NRS was most preferred for every domain separately (45.1 to 50.0%) (Table1).

Conclusion: Mixed results exist with regard to the clinimetric properties of 4 scales to measure the 4 domains. The great majority of patients preferred NRS and NRS showed reasonable to good clinimetric properties for most domains. Therefore we might consider using NRS as the preferable scale for these PROs except may be for general well-being for which the Likert scale has some advantages.

OMERACT aspect Domain Scale Values
r p-value
Truth Pain 1. NRS 0.41 <0.001
  2. VAS 0.40 <0.001
  3. VRS 0.37 <0.001
  4. Likert 0.34 <0.001
  Fatigue 1. VAS 0.16 <0.05
2. Likert 0.14 0.05
3. NRS 0.14 0.05
4. VRS 0.11 0.10
DA 1. VAS 0.35 <0.001
2. NRS 0.32 <0.001
3. Likert 0.31 <0.001
4. VRS 0.28 <0.001
General well-being 1. Likert -0.29 <0.001
2. VRS -0.28 <0.001
3. NRS -0.25 <0.001
4. VAS -0.25 <0.001
Discrimination
Reliability Pain 1. VAS 0.850 <0.001
2. NRS 0.83 <0.001
3. VRS 0.77 <0.001
4. Likert 0.76 <0.001
Fatigue 1. NRS 0.853 <0.001
2. VAS 0.83 <0.001
3. VRS 0.77 <0.001
4. Likert 0.76 <0.001
DA 1. VAS 0.81 <0.001
2. NRS 0.79 <0.001
3. Likert 0.68 <0.001
4. VRS 0.67 <0.001
General well-being 1. Likert 0.57 <0.001
2. VRS 0.53 <0.001
3. NRS 0.50 <0.001
4. VAS 0.49 <0.001
t
Sensitivity to change Pain VAS 2.84 <0.05
Likert 2.34 <0.05
NRS 2.15 <0.05
%
Feasibility
Questionnaire 1 NRS 47.9
Questionnaire 2 NRS 48.4

Table1: Results of best scoring PROs according to OMERACT 2.0 filter


Disclosure: L. Renskers, None; P. L. C. M. van Riel, None; R. J. J. C. van Uden, None.

To cite this abstract in AMA style:

Renskers L, van Riel PLCM, van Uden RJJC. Validity, Reliability and Sensitivity to Change of Four Different Patient-Reported Outcomes (PROs) to Measure the Domains Pain, Fatigue, Experienced Disease Activity and General Well-Being in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/validity-reliability-and-sensitivity-to-change-of-four-different-patient-reported-outcomes-pros-to-measure-the-domains-pain-fatigue-experienced-disease-activity-and-general-well-being-in-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/validity-reliability-and-sensitivity-to-change-of-four-different-patient-reported-outcomes-pros-to-measure-the-domains-pain-fatigue-experienced-disease-activity-and-general-well-being-in-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology